Computer-aided peptide evolution for virtual drug design

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

One of the goals of computational chemistry is the automated de novo design of bioactive molecules. Despite significant progress in computational approaches to ligand design and efficient evaluation of binding energy, novel procedures for ligand design are required. Evolutionary computation provides a new approach to this design issue. A reliable framework for obtaining ligands via evolutionary algorithms has been implemented. It provides an automatic tool for peptide de novo design, based on protein surface patches defined by user. A special emphasis has been given to the evaluation of the proposed peptides. Hence, we have devised two different evaluation heuristics to carry out this task. Then, we have tested the proposed framework in the design of ligands for the protein Prolyl oligopetidase, p53, and DNA Gyrase. ©Springer-Verlag Berlin Heidelberg 2004.

Cite

CITATION STYLE

APA

Belda, I., Llorà, X., Martinell, M., Tarragó, T., & Giralt, E. (2004). Computer-aided peptide evolution for virtual drug design. Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 3102, 321–332. https://doi.org/10.1007/978-3-540-24854-5_34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free